Featured Providers
|
 More
>> |
Shandong Kexing Bioproducts Co., Ltd.
Founded in 1997, Shandong Kexing Bioproducts integrates R&D, manufacture, and sales of biopharmaceuticals. Genzon Group and Shenzhen Kexing Biotech are its major stock holders.
The company develops recombinant gene drugs and micro-ecological drugs, ...Get more info!
Lychee Group LLC
Lychee Group is a media company specializing in China's life sciences industry. Through our targeted events, we bring together the business leaders that are shaping the fastest growing life sciences market in the world.Get more info!
Genescience Pharmaceuticals Co., Ltd.
GeneScience Pharmaceuticals Co., Ltd. (GenSci) is the leading biopharmaceutical company in China focused on developing, manufacturing and marketing protein therapeutic products and biological supergenerics with special emphasis on ...Get more info!
Rundo Cronova International Clinical Research Co.,LTD
Rundo International Clinical Research Co., Ltd is a joint-venture CRO （Contract Research Organization,CRO） corporation founded in March, 2004.
On 22nd Dec. 2007, a new joint-venture company based ...Get more info!
Shanghai BioChip Co., Ltd.
National Engineering Center For BioChip At Shanghai
Shanghai Biochip. Ltd., was founded in August 2001 by some well known universities, research institutes, hospitals and enterprises in China. In Feb.2003, the National Development and Reform Commission consigned SBC to build up and operate National Engineering ...Get more info!
CHINATRIALS is focused exclusively on China’s clinical development industry. No other event goes into as much depth on the issues unique to China. And with pre-arranged off-site visits to hospitals and CROs, we help you make the most of your trip to China. Get more info!
The IDDST congress is initiated by BIT Life Sciences in 2003, with 6 years’ contribution in this field, it has attracted more 800 world renowned speakers with over 40,000 professionals around the world as a leading international event for the professionals to pinpoint and identify opportunities and market needs, explore Asian demand and get updated on latest breakthroughs in drug R&D. Get more info!
BioPharm America™ is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Get more info!
As an annual event of bio-industry, BIOTECH CHINA offers a unique business and communication platform for decision-makers from industry, science and economy and represents an integral and valuable meeting point for both international exhibitors and Asian vendors as well as cooperation partners, distributors and visitors.. Get more info!
The bioeconomy is key to tackling many future global challenges
The biological sciences are adding value to a host of products and services, producing what some have labelled the “bioeconomy”. From a broad economic perspective, the bioeconomy refers to the set of economic activities relating to the invention, development, production and use of biological products and processes. If it continues on course, the bioeconomy could make major socioeconomic contributions in OECD and non-OECD countries. These benefits are expected to improve health outcomes, boost the productivity of agriculture and industrial processes, and enhance environmental sustainability. The bioeconomy’s success is not, however, guaranteed: harnessing its potential will require coordinated policy action by governments to reap the benefits of the biotechnology revolution.
